Interaction between high power 532nm laser and prostatic tissue: in vivo evaluation for laser prostatectomy
暂无分享,去创建一个
Steven Yihlih Peng | Hyun Wook Kang | Ed Koullick | Douglas Stinson | Reza Malek | Michael Beck | H. Kang | R. Malek | D. Stinson | E. Koullick | S. Peng | Michael T Beck
[1] James E. Coad,et al. Developing clinically successful biomedical devices by understanding the pathophysiology of the target tissue: insights from over 25 years at the microscope , 2007, SPIE BiOS.
[2] G. Muir,et al. Photoselective vaporization of the prostate with the potassium‐titanyl‐phosphate laser in men with prostates of >100 mL , 2007, BJU international.
[3] D M Barrett,et al. High-power potassium titanyl phosphate laser vaporization prostatectomy. , 1998, Mayo Clinic proceedings.
[4] Tullio Sulser,et al. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. , 2005, The Journal of urology.
[5] R. Malek. GreenLight™ HPS Laser Therapy for BPH: Clinical Outcomes and Surgical Recommendations from the International GreenLight User (IGLU) Group , 2008 .
[6] M. Hai. Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. , 2009, Urology.
[7] T. Gasser,et al. Comparison of potassium‐titanyl‐phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non‐randomized two‐centre study , 2008, BJU international.
[8] Hyun Wook Kang,et al. Laser vaporization of bovine prostate: a quantitative comparison of potassium-titanyl-phosphate and lithium triborate lasers. , 2008, The Journal of urology.
[9] R. Malek. Photoselective KTP Laser Vaporization of Obstructive BPH (PVP) , 2006 .
[10] H. Kang,et al. Greenlight photoselective 120-watt 532-nm lithium triborate laser vaporization prostatectomy in living canines. , 2009, Journal of endourology.
[11] T. Gasser,et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. , 2008, European urology.
[12] D. M. Barrett,et al. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. , 1998, Urology.
[13] D. Bouchier-Hayes. Photoselective vaporization of the prostate – towards a new standard , 2007, Prostate Cancer and Prostatic Diseases.
[14] H. Woo,et al. Outcome of GreenLight HPS 120-W Laser Therapy in Specific Patient Populations : Those in Retention, on Anticoagulants, and with Large Prostates (≥ 80 ml) , 2008 .
[15] T. Gasser,et al. Prospective single‐centre comparison of 120‐W diode‐pumped solid‐state high‐intensity system laser vaporization of the prostate and 200‐W high‐intensive diode‐laser ablation of the prostate for treating benign prostatic hyperplasia , 2009, BJU international.
[16] D. M. Barrett,et al. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. , 2005, The Journal of urology.
[17] U. Nseyo,et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. , 2004, The Journal of urology.
[18] S. Kaplan,et al. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. , 2004, Urology.
[19] M. Araki,et al. Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). , 2008, Journal of endourology.